Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Fosun Pharma Announces its 15th Corporate Social Responsibility Report: Continuous Innovation for the Benefit of the Public 2023-03-29 14:06
Kintor Pharma Announces Completion of Subject Enrollment in Phase III Clinical Trial of KX-826 for Treatment of Male Androgenetic Alopecia in China 2023-03-28 21:41
PharmaBlock Receives 2023 ACS CMO Excellence in Green Chemistry Award 2023-03-28 20:00
Tigermed Reports Full Year 2022 Results 2023-03-28 19:09
Fosun Pharma Announces 2022 Annual Results: Achieved Steady Growth with Revenue from Record High Innovative Products and Global Commercialization Capability Improvement 2023-03-28 16:20
OncoVent, a Subsidiary of Hepalink, Enters into a License and Distribution Agreement with Orient EuroPharma for the Immunotherapeutic Candidate Oregovomab 2023-03-28 15:36
Acepodia to Present Preclinical Data of Gamma Delta T cell Therapy Candidate, ACE2016, an off-the-shelf EGFR-targeting γδ2 T cell therapy against EGFR-expressing solid tumors 2023-03-28 10:00
BJ Bioscience Announces Clinical Collaboration with MSD to Evaluate BJ-001 in Combination with KEYTRUDA® (pembrolizumab) 2023-03-28 09:19
Noul Co. Ltd - The RIGHT Foundation Commences Research and Development for Supporting Malaria Control 2023-03-27 21:00
Berry Genomics and Ajlan & Bros Holding Subsidiaries Establish a Joint Venture to Support 'Vision 2030' 2023-03-27 20:46
PharmaBlock Opens New R&D Facility in Pennsylvania -- Expanding Capacity to Deliver GMP Projects 2023-03-27 20:00
BIORCHESTRA Pens a Pact Worth up to $861M for Central Nervous System(CNS)-Targeted Polymeric Nanoparticle for Intravenous Delivery of Nucleic Acid Therapies 2023-03-27 20:00
ProfoundBio Highlights Broad Antitumor Activity in Preclinical Models and Trial-in-Progress for PRO1184 at AACR 2023 Annual Meeting 2023-03-24 20:00
Orion Health strengthens North American operations with new technology and leadership 2023-03-24 20:00
Clear Medical Imaging and See-Mode Technologies Announce Partnership via CureLabs Innovation Hub 2023-03-23 21:00
AnPac Bio-Medical Science Granted Continued Listing by NASDAQ Hearing Panel, Subject to Meeting the Equity Rule on or before July 12, 2023 2023-03-23 20:00
111, Inc. Announces Fourth Quarter and Fiscal Year 2022 Financial Results 2023-03-23 14:17
Ascentage Pharma Announces 2022 Annual Results Including Strong Sales of Olverembatinib and Steady Progress in Transition Towards Biopharma 2023-03-23 00:22
Jacobio Pharma Announces 2022 Annual Results 2023-03-22 22:38
Jolly Good and Harvard University Hospital collaborate on medical VR - Full-scale entry into the U.S. market 2023-03-22 21:00
1 107 108 109 110 111 812